cox2 goat (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
93
Structured Review
Santa Cruz Biotechnology
cox2 goat
Cox2 Goat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+cox2/Proliferin+Antibody/pmc12091871__develop-152-204461-s1-100-48-51
Average 93 stars, based on 22 article reviews
Cox2 Goat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+cox2/Proliferin+Antibody/pmc12091871__develop-152-204461-s1-100-48-51
Average 93 stars, based on 22 article reviews
cox2 goat - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Incubation:Article Title: NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis Article Snippet: .. Sections were briefly incubated with the following primary antibodies: Article Title: GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription. Article Snippet: Accepted Manuscript GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription Cheng-Yuan Lai, Ming-Chun Hsieh, Yu-Cheng Ho, Gin-Den Chen, Dylan Chou, Ting Ruan, An-Sheng Lee, Hsueh-Hsiao Wang, Yat-Pang Chau, Hsien-Yu Peng, ChengHung Lai PII: S0028-3908(18)30119-9 DOI: 10.1016/j.neuropharm.2018.03.012 Reference: NP 7115 To appear in: Neuropharmacology Received Date: 22 September 2017 Revised Date: 27 February 2018 Accepted Date: 12 March 2018 Please cite this article as: Lai, C.-Y., Hsieh, M.-C., Ho, Y.-C., Chen, G.-D., Chou, D., Ruan, T., Lee, A.-S., Wang, H.-H., Chau, Y.-P., Peng, H.-Y., Lai, C.-H., GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription, Neuropharmacology (2018), doi: 10.1016/ j.neuropharm.2018.03.012.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia. Article Snippet: .. Blots were blocked with 5% BSA (Sigma, Spain) and incubated overnight at 4 °C with the following antibodies: rabbit anti-iNOS (sc-650, 1:750 BSA 2%; SCBT, USA), Article Title: NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis. Article Snippet: .. Sections were briefly incubated with the following primary antibodies: Article Title: N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia Article Snippet: .. Blots were blocked with 5% BSA (Sigma, Spain) and incubated overnight at 4 °C with the following antibodies: rabbit anti-iNOS (sc-650, 1:750 BSA 2%; SCBT, USA), Acrylamide Gel Assay:Article Title: GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription. Article Snippet: Accepted Manuscript GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription Cheng-Yuan Lai, Ming-Chun Hsieh, Yu-Cheng Ho, Gin-Den Chen, Dylan Chou, Ting Ruan, An-Sheng Lee, Hsueh-Hsiao Wang, Yat-Pang Chau, Hsien-Yu Peng, ChengHung Lai PII: S0028-3908(18)30119-9 DOI: 10.1016/j.neuropharm.2018.03.012 Reference: NP 7115 To appear in: Neuropharmacology Received Date: 22 September 2017 Revised Date: 27 February 2018 Accepted Date: 12 March 2018 Please cite this article as: Lai, C.-Y., Hsieh, M.-C., Ho, Y.-C., Chen, G.-D., Chou, D., Ruan, T., Lee, A.-S., Wang, H.-H., Chau, Y.-P., Peng, H.-Y., Lai, C.-H., GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription, Neuropharmacology (2018), doi: 10.1016/ j.neuropharm.2018.03.012.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Membrane:Article Title: GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription. Article Snippet: Accepted Manuscript GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription Cheng-Yuan Lai, Ming-Chun Hsieh, Yu-Cheng Ho, Gin-Den Chen, Dylan Chou, Ting Ruan, An-Sheng Lee, Hsueh-Hsiao Wang, Yat-Pang Chau, Hsien-Yu Peng, ChengHung Lai PII: S0028-3908(18)30119-9 DOI: 10.1016/j.neuropharm.2018.03.012 Reference: NP 7115 To appear in: Neuropharmacology Received Date: 22 September 2017 Revised Date: 27 February 2018 Accepted Date: 12 March 2018 Please cite this article as: Lai, C.-Y., Hsieh, M.-C., Ho, Y.-C., Chen, G.-D., Chou, D., Ruan, T., Lee, A.-S., Wang, H.-H., Chau, Y.-P., Peng, H.-Y., Lai, C.-H., GluN2B/CaMKII mediates CFA-induced hyperalgesia via HDAC4-modified spinal COX2 transcription, Neuropharmacology (2018), doi: 10.1016/ j.neuropharm.2018.03.012.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. |
